Ziopharm Oncology reported $106.76M in Assets for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Amgen AMGN:US $ 59773M 2766M
Arena Pharmaceuticals ARNA:US $ 1084.66M 99.28M
AstraZeneca AZN:LN 73641M 8715M
Baxter International BAX:US $ 19682M 216M
Biogen BIIB:US $ 24470.4M 615.7M
Bristol Myers Squibb BMY:US $ 110797M 1638M
Corcept Therapeutics CORT:US $ 568.48M 16.08M
Curis CRIS:US $ 181.19M 9.4M
Eleven Biotherapeutics EBIO:US $ 241.05M 54.63M
Gilead Sciences GILD:US $ 67984M 492M
GlaxoSmithKline GSK:LN 77011M 1068M
Immunogen IMGN:US $ 301.45M 44.52M
Intercept Pharmaceuticals ICPT:US $ 523.22M 3.11M
Intrexon XON:US $ 402.57M 4.41M
IONIS PHARMACEUT IONS:US $ 2497.07M 248.52M
Karyopharm Therapeutics KPTI:US $ 286.57M 11.66M
Novartis NOVN:VX SF 124015M 2263M
Ptc Therapeutics PTCT:US $ 2058.67M 53.27M
Regeneron Pharmaceuticals REGN:US $ 21485.9M 3713.7M
Sangamo Biosciences SGMO:US $ 835.36M 41.73M
Tg Therapeutics TGTX:US $ 481.4M 67.3M
Verastem VSTM:US $ 123.89M 13.01M
YTE INCY:US $ 3904.62M 243.19M
Ziopharm Oncology ZIOP:US $ 106.76M 21.71M